These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10566128)

  • 1. [Epidemiology, management and costs of type 2 diabetes in France in 1998].
    Detournay B; Vauzelle-Kervroedan F; Charles MA; Forhan A; Fagnani F; Fender P; Eschwege E
    Diabetes Metab; 1999 Sep; 25(4):356-65. PubMed ID: 10566128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes detection and management among insured adults.
    Dall TM; Yang W; Halder P; Franz J; Byrne E; Semilla AP; Chakrabarti R; Stuart B
    Popul Health Metr; 2016; 14():43. PubMed ID: 27895533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological analysis of patients with Type 2 diabetes in France.
    Grimaldi A; Grangé V; Allannic H; Passa P; Rodier M; Cornet P; Duprat I; Duc-Dodon P; Lemaire A; Liard F; Eschwège E
    J Diabetes Complications; 2000; 14(5):242-9. PubMed ID: 11113685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of French patients with type 2 diabetes mellitus in medical general practice: report of the Mediab observatory.
    Monnier L; Grimaldi A; Charbonnel B; Iannascoli F; Lery T; Garofano A; Childs M;
    Diabetes Metab; 2004 Feb; 30(1):35-42. PubMed ID: 15029096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical resources consumption of type 2 diabetics in France in 1998].
    Detournay B; Fagnani F; Pribil C; Eschwège E
    Diabetes Metab; 2000 May; 26(3):225-31. PubMed ID: 10880898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of Type 2 diabetes and related complications in a nationally representative sample of adults aged 50 and over in the Republic of Ireland.
    Tracey ML; McHugh SM; Buckley CM; Canavan RJ; Fitzgerald AP; Kearney PM
    Diabet Med; 2016 Apr; 33(4):441-5. PubMed ID: 26112979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing type 2 diabetes in France: the ECODIA survey.
    Detournay B; Cros S; Charbonnel B; Grimaldi A; Liard F; Cogneau J; Fagnani F; Eschwège E
    Diabetes Metab; 2000 Nov; 26(5):363-9. PubMed ID: 11119015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The socio-economic cost of diabetic complications in France.
    Triomphe A
    Diabet Med; 1991; 8 Spec No():S30-2. PubMed ID: 1825953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes care and complications in a remote primary health care setting.
    Maple-Brown LJ; Brimblecombe J; Chisholm D; O'Dea K
    Diabetes Res Clin Pract; 2004 May; 64(2):77-83. PubMed ID: 15063599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global burden of diabetes and its complications: an emerging pandemic.
    van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study).
    Halimi S; Zmirou D; Benhamou PY; Balducci F; Zaoui P; Maghlaoua M; Cordonnier D
    Diabetes Metab; 1999 Dec; 25(6):507-12. PubMed ID: 10633876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus.
    Norymberg C; Shenkman L
    Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.
    Bringer J; Fontaine P; Detournay B; Nachit-Ouinekh F; Brami G; Eschwege E
    Diabetes Metab; 2009 Feb; 35(1):25-31. PubMed ID: 19046913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct medical cost of type 2 diabetes.
    Brandle M; Zhou H; Smith BR; Marriott D; Burke R; Tabaei BP; Brown MB; Herman WH
    Diabetes Care; 2003 Aug; 26(8):2300-4. PubMed ID: 12882852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type 2 diabetic patients in a population sample from Ribeirão Preto area (São Paulo)].
    Foss MC; Paccola GM; de Souza NV; Iazigi N
    AMB Rev Assoc Med Bras; 1989; 35(5):179-83. PubMed ID: 2486414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of diabetic patients by general practitioners in France 1997: an epidemiological study.
    Le Floch JP; Thervet F; Desriac I; Boyer JF; Simon D
    Diabetes Metab; 2000 Feb; 26(1):43-9. PubMed ID: 10705103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.